Clinical Trials in Atlanta

Showing 2281-2300 of 16,968 trials

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

NCT05859698

This study will evaluate the effectiveness of valbenazine on patient- and clinician-reported outcomes assessing health-related quality of life, functioning, and treatment effect in participants with tardive dyskinesia (TD) who are receiving valbenazine for up to 24 weeks.

SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more

Neurocrine Biosciences59 participantsStarted May 2023

Bryant, Arkansas, United States • Anaheim, California, United States • Orange, California, United States +15 more locations

Active Not RecruitingPhase 2< 1 mile

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

NCT04448886

This research study is evaluating the safety and effectiveness of Sacituzumab Govitecan with or without Pembrolizumab in metastatic HR+/HER2- breast cancer. The names of the study interventions involved in this study are: * Sacituzumab govitecan (IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)

Invasive Breast CancerMetastatic Breast CancerHR-Positive Breast Cancer+1 more

Ana C Garrido-Castro, MD110 participantsStarted Sep 2020

Atlanta, Georgia, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +5 more locations

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

Find Trials by Condition in Atlanta

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Assessment of CCM in HF With Higher Ejection Fraction

PKU Protein Requirements

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

A Study of DM005 in Patients With Advanced Solid Tumors

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients